These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7941697)

  • 1. Expression of the outer capsid proteins VP2 and VP5 of bluetongue virus in Saccharomyces cerevisiae.
    Martyn JC; Gould AR; Yu M
    Virus Res; 1994 Jul; 33(1):11-25. PubMed ID: 7941697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.
    Lobato ZI; Coupar BE; Gray CP; Lunt R; Andrew ME
    Vet Immunol Immunopathol; 1997 Nov; 59(3-4):293-309. PubMed ID: 9477479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High level expression of the two outer capsid proteins of bluetongue virus serotype 10: their relationship with the neutralization of virus infection.
    Marshall JJ; Roy P
    Virus Res; 1990 Mar; 15(3):189-95. PubMed ID: 2160763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino acid sequence of the outer coat protein VP2 of neutralizing monoclonal antibody-resistant, virulent and attenuated bluetongue viruses.
    Gould AR; Eaton BT
    Virus Res; 1990 Nov; 17(3):161-72. PubMed ID: 1706548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype.
    Mertens PP; Pedley S; Cowley J; Burroughs JN; Corteyn AH; Jeggo MH; Jennings DM; Gorman BM
    Virology; 1989 Jun; 170(2):561-5. PubMed ID: 2543130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topography and immunogenicity of bluetongue virus VP7 epitopes.
    Wang LF; Hyatt AD; Whiteley PL; Andrew M; Li JK; Eaton BT
    Arch Virol; 1996; 141(1):111-23. PubMed ID: 8629938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High level expression of the major core protein VP7 and the non-structural protein NS3 of bluetongue virus in yeast: use of expressed VP7 as a diagnostic, group-reactive antigen in a blocking ELISA.
    Martyn JC; Gould AR; Eaton BT
    Virus Res; 1991 Mar; 18(2-3):165-78. PubMed ID: 1645903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus.
    Martínez-Torrecuadrada JL; Langeveld JP; Venteo A; Sanz A; Dalsgaard K; Hamilton WD; Meloen RH; Casal JI
    Virology; 1999 May; 257(2):449-59. PubMed ID: 10329555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an amino acid on VP2 that affects neutralization of bluetongue virus serotype 10.
    Jewell JE; Mecham JO
    Virus Res; 1994 Aug; 33(2):139-44. PubMed ID: 7975878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence conservation of the outer capsid protein, VP5, of bluetongue virus, a contrasting feature to the outer capsid protein VP2.
    Oldfield S; Hirasawa T; Roy P
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():449-51. PubMed ID: 1847179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies.
    DeMaula CD; Bonneau KR; MacLachlan NJ
    Virus Res; 2000 Mar; 67(1):59-66. PubMed ID: 10773319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
    Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
    Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep.
    Boone JD; Balasuriya UB; Karaca K; Audonnet JC; Yao J; He L; Nordgren R; Monaco F; Savini G; Gardner IA; Maclachlan NJ
    Vaccine; 2007 Jan; 25(4):672-8. PubMed ID: 17059856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence analysis and in vitro expression of a cDNA clone of genome segment 5 from bluetongue virus, serotype 1 from South Africa.
    Wade-Evans AM; Pan ZQ; Mertens PP
    Virus Res; 1988 Oct; 11(3):227-40. PubMed ID: 2848383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccine prime and recombinant FPV vaccine boost: an important candidate immunization strategy to control bluetongue virus type 1.
    Li J; Yang T; Xu Q; Sun E; Feng Y; Lv S; Zhang Q; Wang H; Wu D
    Appl Microbiol Biotechnol; 2015 Oct; 99(20):8643-52. PubMed ID: 26048472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved and non-conserved regions of the outer coat protein, VP2, of the Australian bluetongue serotype 1 virus, revealed by sequence comparison to the VP2 of North American BTV serotype 10.
    Gould AR
    Virus Res; 1988 Feb; 9(2-3):145-58. PubMed ID: 2833046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myxomavirus as a vector for the immunisation of sheep: protection study against challenge with bluetongue virus.
    Top S; Foucras G; Deplanche M; Rives G; Calvalido J; Comtet L; Bertagnoli S; Meyer G
    Vaccine; 2012 Feb; 30(9):1609-16. PubMed ID: 22244980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the outer capsid protein VP5 of two bluetongue viruses, and synthesis of chimeric double-shelled virus-like particles using combinations of recombinant baculoviruses.
    Loudon PT; Hirasawa T; Oldfield S; Murphy M; Roy P
    Virology; 1991 Jun; 182(2):793-801. PubMed ID: 1850928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete nucleotide and deduced amino acid sequence of genome segment 5 encoding the outer capsid protein, VP5, of a U.S. isolate of bluetongue virus serotype 11.
    Dunn SJ; Hsu D; Zee YC; Stott JL
    Virus Res; 1991 Oct; 21(2):155-62. PubMed ID: 1661982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of recombinant baculoviruses expressing the outer capsid protein VP2 of five BTV serotypes and the induction of neutralizing antibodies to homologous and heterologous BTV serotypes.
    Urakawa T; French TJ; Adachi Y; Fukusho A; LeBlois H; Flamand M; Mertens P; Roy P
    Virus Res; 1994 Feb; 31(2):149-61. PubMed ID: 8178571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.